| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $23,453,401 ) (Continued on the next page) |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21AI194056 | Evaluating regimen efficacy using transcriptomic patterns of Mycobacterium tuberculosis injury and adaptation: high dimensional pharmacodynamics as a steppingstone to rational regimen design. | 000 | 1 | NIH | 8/8/2025 | $429,546 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 00 | 23 | HRSA | 6/23/2025 | $1,086,913 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI173502 | SUNBEAM Birth Cohort Supplement | 001 | 2 | NIH | 8/28/2025 | $200,000 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI173502 | SUNBEAM Birth Cohort Supplement | 000 | 2 | NIH | 7/7/2025 | $1,308,830 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI152037 | ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | 000 | 6 | NIH | 3/31/2025 | $329,638 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 001 | 13 | NIH | 7/16/2025 | $71,477 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 000 | 13 | NIH | 3/3/2025 | $643,294 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL177550 | Role of the SFTA2/ADGRF5 signaling axis in alveolar homeostasis | 000 | 1 | NIH | 8/22/2025 | $702,103 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173030 | Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | 000 | 2 | NIH | 4/15/2025 | $610,880 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173030 | Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | 001 | 2 | NIH | 6/26/2025 | $67,876 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 01 | 2 | HRSA | 8/18/2025 | $48,215 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 00 | 2 | HRSA | 7/24/2025 | $167,366 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 001 | 4 | NIH | 9/3/2025 | $99,600 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 000 | 4 | NIH | 1/8/2025 | $896,400 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R00HL161320 | RNA editing controls pulmonary endothelial pathophenotypes in pulmonary hypertension | 001 | 4 | NIH | 8/13/2025 | $249,000 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL162955 | Molecular Characterization of Progressive Pulmonary Sarcoidosis | 000 | 3 | NIH | 8/19/2025 | $784,774 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL166938 | Interaction of fibroblasts with cell corpses increases collagen synthesis during lung repair | 000 | 3 | NIH | 7/2/2025 | $623,931 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21HL175174 | Common and distinct metabolic pathways of pulmonary sarcoidosis phenotypes and endotypes | 000 | 1 | NIH | 6/12/2025 | $249,000 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL167956 | GM-CSF, macrophages, and susceptibility to Mycobacterium abscessus pulmonary infection | 000 | 3 | NIH | 5/16/2025 | $620,636 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AG073317 | Loss of progenitor function accelerates lung aging | 000 | 3 | NIH | 7/30/2025 | $672,911 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01ES033678 | Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease | 000 | 4 | NIH | 11/27/2024 | $636,949 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08ES034820 | Transcriptional Responses to Wildfire Pollution in Airway Epithelial Cells Identify Genetic Risk Factors and Mechanisms of Asthma Exacerbations | 000 | 3 | NIH | 12/16/2024 | $174,528 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL157424 | Proteolysis in the Pathogenesis of ARDS | 001 | 4 | NIH | 8/12/2025 | $68,322 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL157424 | Proteolysis in the Pathogenesis of ARDS | 000 | 4 | NIH | 11/12/2024 | $614,895 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL155325 | Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance | 001 | 5 | NIH | 6/26/2025 | $47,749 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL155325 | Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance | 000 | 5 | NIH | 4/9/2025 | $429,742 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI165922 | DNA induction of neutrophilic asthma | 000 | 5 | NIH | 8/27/2025 | $511,805 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL144727 | Mechanisms of right ventricle adaptation to pulmonary hypertension | 002 | 6 | NIH | 8/27/2025 | $726,487 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL141264 | Role of FABP5 in COPD Exacerbations | 002 | 6 | NIH | 7/1/2025 | $591,985 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL155894 | Interstitial macrophages in cigarette smoke-induced small airway remodeling | 000 | 4 | NIH | 12/23/2024 | $158,328 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K01DK134835 | Transcriptional control of T cell function during type 1 diabetes | 000 | 2 | NIH | 12/11/2024 | $114,626 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI182277 | Mast Cell Lineage Commitment and Function | 000 | 1 | NIH | 12/2/2024 | $612,328 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL171850 | Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling | 001 | 2 | NIH | 7/2/2025 | $156,816 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL168278 | Reparative functions of human airspace macrophage subsets | 000 | 2 | NIH | 7/11/2025 | $602,955 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173239 | Integrative Metabolomics of Sarcoidosis Diagnosis and Progression | 000 | 1 | NIH | 4/1/2025 | $760,374 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 003 | 6 | NIH | 9/4/2025 | $3,500,000 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 001 | 6 | NIH | 4/7/2025 | $4,349,476 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 000 | 5 | NIH | 2/28/2025 | $523,165 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI151021 | Transcriptional Control of T Cell Function | 000 | 5 | NIH | 3/17/2025 | $397,700 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 02 | 22 | HRSA | 12/11/2024 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AR077511 | Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy | 000 | 5 | NIH | 8/13/2025 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AR077511 | Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy | 000 | 5 | NIH | 8/13/2025 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 02 | 1 | HRSA | 1/22/2025 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 01 | 1 | HRSA | 11/29/2024 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R56AI180204 | Transcriptional Regulation of the Il13 Gene in Mast Cells | 000 | 1 | NIH | 5/12/2025 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R00HL161320 | RNA editing controls pulmonary endothelial pathophenotypes in pulmonary hypertension | 000 | 3 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R13HL174110 | Aspen Lung Conference Pulmonary Fibrosis - focusing on the future | 000 | 1 | NIH | 8/5/2025 | -$1,452 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL144727 | Mechanisms of right ventricle adaptation to pulmonary hypertension | 000 | 5 | NIH | 12/11/2024 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL141264 | Role of FABP5 in COPD Exacerbations | 001 | 5 | NIH | 4/3/2025 | $35,285 |
|
